NCT01972776 A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076. Status TERMINATED Phase PHASE2
NCT01968915 Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01964235 Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE2
NCT01961609 Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants. Status COMPLETED Phase PHASE3
NCT01959516 Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD Status COMPLETED Phase PHASE4
NCT01959412 Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma Status COMPLETED Phase PHASE2
NCT01958918 Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD Status COMPLETED Phase PHASE4
NCT01958021 Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT01957176 A Rollover Study to Provide Continued Treatment With Eltrombopag Status COMPLETED Phase PHASE4
NCT01956669 Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors Status COMPLETED Phase PHASE2
NCT01952015 Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) Status COMPLETED Phase PHASE3
NCT01950819 Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) Status COMPLETED Phase PHASE4
NCT01948830 Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD Status COMPLETED Phase PHASE3
NCT01948817 Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses Status WITHDRAWN Phase PHASE2
NCT01948791 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients Status COMPLETED Phase PHASE4
NCT01947608 Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC Status NO_LONGER_AVAILABLE Phase N/A
NCT01936519 Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation. Status COMPLETED Phase NA
NCT01935128 Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction Status COMPLETED Phase PHASE4